3D, Dynamic and Mechanically-informed Decision Making in AIS
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Feb 15, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Adolescent Idiopathic Scoliosis (AIS) is a growth defect of the spine that primarily occurs in prepubertal children between the age of 10 to 14 years, affecting approximately 3% of these otherwise normal children. The spine, which is normally straight in a posterior view, forms one or two lateral curves with associated turns around its longitudinal axis, like a spiral staircase. AIS has been associated with problems related to posture, load-related back pain, as well as aesthetic problems, e.g. the induced asymmetry of the shoulder. Therefore, early diagnosis followed by the appropriate tre...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient diagnosed with Adolescent Idiopathic Scoliosis
- • 10-35 years old
- • Patient is scheduled to be surgically treated by vertebral body tethering (VBT) or selective fusion at UZ Leuven
- • Informed consent obtained: also from parent/guardian in case of minors
- Exclusion Criteria:
- • Patient has undergone a fusion or VBT procedure before
- • Patient has a severe underlying illness which might influence the outcome of the surgery
- • Making it reasonable for the investigator to exclude the patient
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, Vlaams Brabant, Belgium
Patients applied
Trial Officials
Sebastiaan Schelfaut
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials